Skip to main content

Table 2 The frequency and intensity of HPV16 E6 single peptide-specific T cell response

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

HPV16 E6 peptide

Squamous cell carcinoma of cervix (n = 76)

Frequency (%)

Mean magnitude (SFC/106)

E6 Peptide-1MHQKRTAMFQDPQERPRK1-18

6.58

39.80

E6 Peptide-2 FQDPQERPRKLPQLCTEL9-26

9.21

44.00

E6 Peptide-3 RKLPQLCTELQTTIHDII17-34

9.21

41.00

E6 Peptide-4 ELQTTIHDIILECVYCKQ25-42

10.53

41.62

E6 Peptide-5 IILECVYCKQQLLRREVY33-50

10.53

40.37

E6 Peptide-6 KQQLLRREVYDFAFRDLC41-58

6.58

45.20

E6 Peptide-7 VYDFAFRDLCIVYRDGNP49-66

9.21

45.85

E6 Peptide-8 LCIVYRDGNPYAVCDKCL57-74

9.21

46.14

E6 Peptide-9 NPYAVCDKCLKFYSKISE65-82

10.53

38.37

E6 Peptide-10 CLKFYSKISEYRHYCYSV73-90

19.74

40.20

E6 Peptide-11 SEYRHYCYSVYGTTLEQQ81-98

11.84

44.33

E6 Peptide-12 SVYGTTLEQQYNKPLCDL89-106

7.89

45.50

E6 Peptide-13 QQYNKPLCDLLIRCINCQ97-114

10.53

33.50

E6 Peptide-14 DLLIRCINCQKPLCPEEK105-122

19.74

44.20

E6 Peptide-15 CQKPLCPEEKQRHLDKKQ113-130

14.47

49.82

E6 Peptide-16 EKQRHLDKKQRFHNIRGR121-138

17.11

37.3

E6 Peptide-17 KQRFHNIRGRWTGRCMS129-146

17.11

47.84

E6 Peptide-18 GRWTGRCMSCCRSSRTRR137-154

10.53

44.37

  1. HPV, human papillomavirus